detected the MYD88 L265P mutation in cfDNA during and after chemotherapy treatments in five patients with PCNSL, among whom the MYD88 L265P mutation was detected in cfDNA at diagnosis (67). Here, MYD88 is linked to primary central nervous system lymphoma.